ABCG2 and cancer: Circumvention of cancer drug resistance may be achieved either by inhibition of ABC transporter activity using specific small molecules (e.g., verapamil) or by the enhanced entry of an anticancer drug into the cytoplasm or nuclei in a way not vulnerable to ABC transporter-mediated efflux from the membrane bilayer.